Holen Sie sich die Stockscreener-App
6.93
8.11%
0.52
Handel nachbörslich:
6.99
0.06
+0.87%
Schlusskurs vom Vortag:
$6.41
Offen:
$6.4
24-Stunden-Volumen:
598.34K
Relative Volume:
4.35
Marktkapitalisierung:
$590.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.64M
KGV:
-16.12
EPS:
-0.43
Netto-Cashflow:
$-39.43M
1W Leistung:
+43.48%
1M Leistung:
+63.83%
6M Leistung:
+112.58%
1J Leistung:
+94.66%
1-Tages-Spanne:
$6.3898
$6.99
1-Wochen-Bereich:
$4.90
$6.99
52-Wochen-Spanne:
$2.30
$6.99
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Firmenname
Alpha Tau Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie DRTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
6.93 | 546.54M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-15 | Eingeleitet | Citigroup | Buy |
| 2023-04-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-04 | Eingeleitet | Citigroup | Buy |
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
Is Alpha Tau Medical Ltd. stock positioned well for digital economyJuly 2025 Update & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Is Alpha Tau Medical Ltd. stock positioned for long term growthChart Signals & Precise Swing Trade Entry Alerts - ulpravda.ru
Will Alpha Tau Medical Ltd. stock deliver strong dividend growthWall Street Watch & Low Risk Entry Point Tips - ulpravda.ru
Is Alpha Tau Medical Ltd. stock cheap at current valuationPerformance Line Overview & what to check before ordering - ulpravda.ru
How risky is Alpha Tau Medical Ltd. Equity Warrant stock nowMarket Performance Summary & Consistent Profit Alerts - ulpravda.ru
Will Alpha Tau Medical Ltd. stock pay special dividendsJuly 2025 Levels & Safe Swing Trade Setups - ulpravda.ru
Will Alpha Tau Medical Ltd. stock deliver better than expected guidanceJuly 2025 Breakouts & Free Safe Entry Trade Signal Reports - ulpravda.ru
Will Alpha Tau Medical Ltd. stock benefit from infrastructure spending2025 Trading Recap & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock supported by strong cash flowsMarket Sentiment Summary & Reliable Momentum Entry Alerts - ulpravda.ru
How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stockJuly 2025 Gainers & Daily Momentum Trading Reports - ulpravda.ru
Will Alpha Tau Medical Ltd. Equity Warrant stock sustain high P E ratiosQuarterly Portfolio Report & High Win Rate Trade Tips - ulpravda.ru
Is Alpha Tau Medical Ltd. stock a buy in volatile marketsEarnings Performance Report & Fast Gain Swing Trade Alerts - ulpravda.ru
Is Alpha Tau Medical Ltd. stock supported by strong fundamentalsProfit Target & Safe Entry Trade Signal Reports - ulpravda.ru
Why Alpha Tau Medical Ltd. stock remains a top recommendation2025 Year in Review & Free Weekly Watchlist of Top Performers - ulpravda.ru
Alpha Tau Medical Ltd.Ordinary Shares (NQ: DRTS - FinancialContent
Dental EconomicsAlpha Tau Medical Ltd.Ordinary Shares (Nasdaq:DRTS) Price Chart - FinancialContent
Alpha Tau Medical to present corporate update at JP Morgan 2026 Healthcare Conference - MSN
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks
Alpha Tau reports new positive results in two upcoming presentations - MarketScreener
Pancreatic cancer trial finds immune-sparing radiation with 81% disease control - Stock Titan
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating - Investing.com
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical - TipRanks
Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation - The Globe and Mail
Alpha Tau files first FDA PMA module for Alpha DaRT skin cancer therapy - MSN
Bond Watch: Is Alpha Tau Medical Ltd stock a buy before product launchesJuly 2025 Gainers & Long-Term Capital Growth Strategies - moha.gov.vn
Alpha Tau submits first pre-market approval module to the FDA - MarketScreener
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy - TipRanks
Alpha Tau submits PMA module to FDA for Alpha DaRT - TipRanks
New radiation implant edges closer for tough-to-treat skin cancer patients - Stock Titan
What drives Alpha Tau Medical Ltd stock priceSwing Trading Watchlist & High Return Capital Gains - earlytimes.in
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Graphite India Limited At Decision Level — Rebound or ResistanceSupport Zone Identification & Double Digit Profit Strategies - bollywoodhelpline.com
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 58.8% in December - MarketBeat
Pharma News: Can Alpha Tau Medical Ltd Equity Warrant stock hit record highs again2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
How supply chain issues affect Alpha Tau Medical Ltd. stock2025 Market Overview & AI Driven Price Predictions - Улправда
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium - MSN
Will Alpha Tau Medical Ltd. stock attract more institutional investorsPortfolio Performance Report & Accurate Trade Setup Notifications - Улправда
Entry Recap: How supply chain issues affect Alpha Tau Medical Ltd. stockJuly 2025 Earnings & Weekly High Potential Alerts - Улправда
Will Alpha Tau Medical Ltd. stock deliver shareholder valueQuarterly Profit Review & Verified Short-Term Plans - Улправда
Market Recap: What insider trading reveals about Alpha Tau Medical Ltd. stockJuly 2025 Drop Watch & Risk Managed Investment Signals - Улправда
Alpha Tau Medical’s innovative cancer treatment study update: A potential game-changer - MSN
Is Alpha Tau Medical Ltd. stock a buy before product launches2025 AllTime Highs & Fast Gain Swing Alerts - Bölüm Sonu Canavarı
Will Alpha Tau Medical Ltd. Equity Warrant stock outperform Nasdaq index2025 Volume Leaders & AI Powered Market Trend Analysis - Улправда
Why Alpha Tau Medical Ltd. stock is seen as undervaluedTrade Volume Report & Stock Timing and Entry Methods - Улправда
Will Alpha Tau Medical Ltd. stock attract ESG investorsWeekly Stock Report & Daily Volume Surge Signals - Улправда
How Alpha Tau Medical Ltd. Equity Warrant stock performs during Fed tightening cyclesWeekly Profit Recap & Long-Term Growth Portfolio Plans - DonanımHaber
Aug Levels: Will Alpha Tau Medical Ltd. stock attract more institutional investorsJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Finanzdaten der Alpha Tau Medical Ltd-Aktie (DRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):